Revenue grew 17% to NOK 9.8 billion, with strong pelagic and salmon segment performance. Despite a negative fair value adjustment on biological assets, operational EBITDA and EBIT improved year-over-year. Salmon volumes and biological performance were notably strong.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.